BioPharma Co. Escapes Investor Tumor Therapy Suit
A group of shareholders read too much into drug company statements they said misled them about the promise of a developing tumor treatment in clinical trials, a Washington federal judge ruled...To view the full article, register now.
Already a subscriber? Click here to view full article